Skip to header Skip to main navigation Skip to main content Skip to footer
Home
Academic Citations from Palestine
Foregrounding the Research of Academics in Palestine

Main navigation

  • Home
  • Search
  • About

Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials

Blank
Al-Azhar University – Gaza
Abouelmagd M.E.; Almosilhy N.A.; Makhlouf H.A.; Hassan A.K.; Osman A.S.A.; Hindawi M.D.; Elshahat A.; Alnajjar A.Z.; Mustafa M.M.M.; Abdelsalam O.K.; Mady A.; Shaheen A.; Barrett M.J.; Negida A.
Abouelmagd, Moaz Elsayed (58781741300); Almosilhy, Nereen A. (59352403400); Makhlouf, Hamdy A. (59316072500); Hassan, Amr K. (57220065688); Osman, Ahmed S. A. (59486073100); Hindawi, Mahmoud Diaa (59203625000); Elshahat, Ahmed (58504579600); Alnajjar, Asmaa Zakria (58648008200); Mustafa, Mohamed M. M. (59495493300); Abdelsalam, Omar Khaled (60035980000); Mady, Abdelrahman (59245541100); Shaheen, Ahmed (57221692249); Barrett, Matthew J. (56486930700); Negida, Ahmed (56845873000)
58781741300; 59352403400; 59316072500; 57220065688; 59486073100; 59203625000; 58504579600; 58648008200; 59495493300; 60035980000; 59245541100; 57221692249; 56486930700; 56845873000
2025
Systematic Reviews
Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials
14
1
BioMed Central Ltd
213
Kasr-Alainy Faculty of Medicine, Cairo University, Cairo, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt; Faculty of Medicine, Minia University, Minia, Egypt; School of Medicine, University of California, Irvine, CA, United States; Faculty of Medicine, Al-Azhar University, Cairo, Egypt; Faculty of Medicine, Al-Azhar University, Gaza, Palestine; Faculty of Pharmacy, Egyptian Russian University, Badr City, Egypt; Faculty of Medicine, New Mansoura University, New Mansoura, Egypt; Alexandria Faculty of Medicine, Alexandria, Egypt; Department of Neurology, Virginia Commonwealth University, Richmond, VA, United States; Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; BrainLat Institute, School of Psychology, Adolfo Ibáñez University, Santiago, Chile
Abouelmagd M.E., Kasr-Alainy Faculty of Medicine, Cairo University, Cairo, Egypt; Almosilhy N.A., Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt; Makhlouf H.A., Faculty of Medicine, Minia University, Minia, Egypt; Hassan A.K., School of Medicine, University of California, Irvine, CA, United States, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; Osman A.S.A., Faculty of Medicine, Minia University, Minia, Egypt, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; Hindawi M.D., Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; Elshahat A., Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; Alnajjar A.Z., Faculty of Medicine, Al-Azhar University, Gaza, Palestine, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; Mustafa M.M.M., Faculty of Pharmacy, Egyptian Russian University, Badr City, Egypt, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; Abdelsalam O.K., Faculty of Medicine, New Mansoura University, New Mansoura, Egypt, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; Mady A., Faculty of Medicine, Al-Azhar University, Cairo, Egypt, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States; Shaheen A., Alexandria Faculty of Medicine, Alexandria, Egypt, BrainLat Institute, School of Psychology, Adolfo Ibáñez University, Santiago, Chile; Barrett M.J., Department of Neurology, Virginia Commonwealth University, Richmond, VA, United States; Negida A., Department of Neurology, Virginia Commonwealth University, Richmond, VA, United States, Medical Research Group of Egypt, Negida Academy, Arlington, MA, United States
M.E. Abouelmagd; Kasr-Alainy Faculty of Medicine, Cairo University, Cairo, Egypt; email: moaz.s.sayed@gmail.com
0
10.1186/s13643-025-02961-6
Adverse events; Cholinesterase inhibitors; Dementia; Memantine; Network meta-analysis; Protocol
Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Humans; Memantine; Meta-Analysis as Topic; Network Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Systematic Reviews as Topic; cholinesterase inhibitor; donepezil; galantamine; memantine; rivastigmine; cholinesterase inhibitor; memantine; agitation; Alzheimer disease; Article; cardiovascular disease; cerebrovascular accident; cognition; comparative study; controlled study; dementia; diarrhea; diffuse Lewy body disease; dizziness; drug safety; faintness; falling; headache; heart infarction; human; meta analysis; Mini Mental State Examination; nausea; network meta-analysis; Parkinson disease; quality control; randomized controlled trial (topic); skin disease; sleep disorder; systematic review; dementia; drug therapy; meta analysis (topic); network meta analysis (topic); systematic review (topic)